Ginkgo Bioworks Holdings (DNA) Other Non-Current Liabilities (2019 - 2026)

Ginkgo Bioworks Holdings' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $21.7 million for Q1 2026.

• Quarterly Other Non-Current Liabilities rose 40.84% year-over-year to $21.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.7 million (up 40.84% YoY) and the FY2025 annual result came in at $22.9 million, up 38.01% from the prior year.
• Other Non-Current Liabilities was $21.7 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $22.9 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $39.7 million in Q3 2022 and bottomed at $9.0 million in Q2 2022.
• A 5-year average of $20.3 million and a median of $17.9 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Peak annual rise in Other Non-Current Liabilities reached 194.01% in 2023, while the deepest fall reached 69.16% in 2023.
• Ginkgo Bioworks Holdings' Other Non-Current Liabilities stood at $31.2 million in 2022, then declined by 21.67% to $24.4 million in 2023, then plunged by 32.16% to $16.6 million in 2024, then jumped by 38.01% to $22.9 million in 2025, then fell by 5.0% to $21.7 million in 2026.
• Business Quant data shows DNA's Other Non-Current Liabilities at $21.7 million in Q1 2026, $22.9 million in Q4 2025, and $17.2 million in Q3 2025.